What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Objectives: Antidepressant prescribing almost doubled in the Netherlands between 1996 and 2012, which could be accounted for by longer continuation after the first prescription. This might be problematic given a growing concern of large-scale antidepressant dependence. We aimed to assess the extent and determinants of chronic antidepressant prescribing among patient aged 18 years and older. We hypothesise a relatively large prevalence of chronic (>2 years) prescription. Design: A longitudinal observational study based on routinely registered prescription data from general practice. Setting: 189 general practices in the Netherlands. Participants: 326 025 patients with valid prescription data for all 5 years of the study. Outcome measures: Primary outcome measure: the number of patients (N) receiving at least four antidepressant prescriptions in 2011, as well as during each of the four subsequent years. Secondary outcome measure: the above, but specified for selective serotonin reuptake inhibitors and for tricyclic antidepressants. Results: Antidepressants were prescribed to almost 7% of our 326 025 participants each year. They were prescribed for depression (38%), anxiety (17%), other psychological disorders (20%) and non-psychological indications (25%). Antidepressants were prescribed in all 5 years to the 42% of the population who had at least four prescriptions dispensed in 2011. Chronic prescribing was higher among women than men, for those aged 45–64 years than for those aged >65 years and for those treated for depression or anxiety than for non-psychological indications (eg, neuropathic pain). Chronic prescribing also varied markedly among general practices. Conclusion: Chronic antidepressant use is common for depression and for anxiety and non-psychological diagnoses. Once antidepressants have been prescribed, general practitioners and other prescribers should be aware of the risks associated with long-term use and should provide annual monitoring of the continued need for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, research indicates that in the Netherlands, 75% of antidepressant indications are for depression, anxiety and other mental disorders and only 25% for non-mental indications, and that this 3:1 ratio increases further in the population with persistent use, as the majority in our sample. 33”
From Outcomes of hyperbolic tapering of antidepressants (2023) · cites this paper as [33]
In the citing paper
“Research further indicates that many people in receipt of long-term antidepressant medication do not necessarily require maintenance treatment.7,9,10”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
International Classification of Primary Care
Bentsen, B. G. (1986) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813438609013970 · Cited by 898
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833 · cited 2×
“26 27 A higher risk for falls, attempted suicides, stroke, fracture and epilepsy is reported for older people, using AD.”
ResultInfluences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
Mojtabai, R., & Olfson, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08443 · Cited by 247
Wong, J., Motulsky, A., Abrahamowicz, M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. (2017) · BMJ · doi:10.1136/bmj.j603 · Cited by 221
Cuijpers, P., van Straten, A., van Oppen, P., & Andersson, G. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1102 · Cited by 219
Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race
Moore, T. J., & Mattison, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.7507 · Cited by 207 · cited 1×
“Based on evidence that they are more efficacious than placebo in adults with major depressive disorder,(1) antidepressants were used by more than 12% of the adult US population in 2013, with the prevalence in women being approximately double than in men, and increasing with age.(2) However, antidepressants are also pr…”
BackgroundNoordam, R., Aarts, N., Verhamme, K. M. C., Sturkenboom, M., Stricker, B. H. C., & Visser, L. E. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1803-x · Cited by 158
[International classification of primary care].
Ewert, R., & Perthel, M. (1992) · PubMed · Cited by 156
Manufacturing Depression: The Secret History of a Modern Disease
Greenberg, G. (2010) · Cited by 136
Incidence and determinants of long-term use of antidepressants
Meijer, W. E. E., Heerdink, E. R., Leufkens, H. G. M., Herings, R. M. C., Egberts, T. C. G., & Nolen, W. A. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0726-3 · Cited by 127
Lockhart, P., & Guthrie, B. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x593848 · Cited by 123
Coupland, C. A. C., Hill, T., Morriss, R. K., Moore, M. V., Arthur, A. J., & Hippisley‐Cox, J. (2018) · BMC Medicine · doi:10.1186/s12916-018-1022-x · Cited by 122
Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
Mark, T. L., Joish, V. N., Hay, J. W., Sheehan, D. V., Johnston, S. S., & Cao, Z. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181f1803d · Cited by 112
Prevalence, duration and indications for prescribing of antidepressants in primary care
Petty, D. R., House, A., Knapp, P., Raynor, T., & Zermansky, A. (2006) · Age and Ageing · doi:10.1093/ageing/afl023 · Cited by 110 · cited 1×
“4 years for anxiety and 5 years for pain.(19) Read et al also reported that 52% of a New Zealand sample continued antidepressant treatment for 3 or more years, with this proportion increasing with age,(20) while Ambresin et al reported that therapy was continued for more than 2 years in 47% of antidepressant users.”
BackgroundDoes long term use of psychiatric drugs cause more harm than good?
Gotzsche, P. C., Young, A. H., & Crace, J. (2015) · BMJ · doi:10.1136/bmj.h2435 · Cited by 104
Hill, T., Coupland, C., Morriss, R., Arthur, A., Moore, M., & Hippisley-Cox, J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0701-9 · Cited by 91
'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses
Johnson, C. F., Williams, B., MacGillivray, S. A., Dougall, N. J., & Maxwell, M. (2017) · BMC Family Practice · doi:10.1186/s12875-017-0643-z · Cited by 86
Bosman, R. C., Huijbregts, K. M., Verhaak, P. F., Ruhé, H. G., van Marwijk, H. W., van Balkom, A. J., & Batelaan, N. M. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x686641 · Cited by 76 · cited 1×
“This is compounded by the fact that, when patients have benefited from relief of depressive symptoms, they often become reluctant to stop therapy for fear of becoming depressed again.(35) Therefore, large groups of patients with single episodes of low severity depression, who probably received effective antidepressant…”
BackgroundSelf-citationHanlon, J. T., Wang, X., Castle, N. G., Stone, R. A., Handler, S. M., Semla, T. P., Pugh, M. J., Berlowitz, D. R., & Dysken, M. W. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03522.x · Cited by 74
Huijbregts, K. M., Hoogendoorn, A., Slottje, P., van Balkom, A. J. L. M., & Batelaan, N. M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480456 · Cited by 68
NHG-Standaard Depressie (tweede herziening)
van Weel-Baumgarten, E. M., van Gelderen, G., Grundmeijer, H. G. L. M., Licht-Strunk, E., van Marwijk, H., van Rijswijk, E., Tjaden, B., Verduijn, M. M., Wiersma, T., Burgers, J. S., et al. (2012) · Huisarts en Wetenschap · Cited by 67
Accuracy of general practitioner unassisted detection of depression
Carey, M., Jones, K., Meadows, G., Sanson-Fisher, R., D’Este, C., Inder, K., Yoong, S. L., & Russell, G. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413520047 · Cited by 66
Burton, C., Anderson, N., Wilde, K., & Simpson, C. R. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x625166 · Cited by 49
New users of antidepressant medications: first episode duration and predictors of discontinuation
Lu, C. Y., & Roughead, E. E. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1087-3 · Cited by 43
Sihvo, S., Wahlbeck, K., McCallum, A., Sevon, T., Arffman, M., Haukka, J., Keskimäki, I., & Hemminki, E. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2017 · Cited by 41
Harris, T. J., Carey, I. M., Shah, S. M., DeWilde, S., & Cook, D. G. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.09.005 · Cited by 35
Aarts, N., Noordam, R., Hofman, A., Tiemeier, H. W., Stricker, B. H. C., & Visser, L. E. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0371-9 · Cited by 31
Practice variation on use of antibiotics: An international survey among pediatric urologists
Kim, J. K., Chua, M. E., Ming, J. M., Braga, L. H., Smith, G., Driver, C. P., & Koyle, M. A. (2018) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2018.04.018 · Cited by 28
Sinclair, J. E., Aucott, L. S., Lawton, K., Reid, I. C., & Cameron, I. M. (2014) · Family Practice · doi:10.1093/fampra/cmu019 · Cited by 27
Provider Variation in Antibiotic Prescribing and Outcomes of Respiratory Tract Infections
Manne, M. B., Deshpande, A., Hu, B., Patel, A., Taksler, G. B., Misra‐Hebert, A. D., Jolly, S. E., Brateanu, A., Bales, R. W., & Rothberg, M. B. (2018) · Southern Medical Journal · doi:10.14423/smj.0000000000000795 · Cited by 26
Depression and use of antidepressants in Swedish nursing homes: a 12-month follow-up study
Midlöv, P., Andersson, M., Östgren, C. J., & Mölstad, S. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213002354 · Cited by 17
[Taperingstrips for paroxetine and venlafaxine].
Groot, P. C. (2013) · PubMed · Cited by 12
Read, J., Gibson, K. L., & Cartwright, C. (2016) · Australian Journal on Ageing · doi:10.1111/ajag.12314 · Cited by 11
Burton, C. D., Cameron, I. M., & Anderson, N. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x683557 · Cited by 9
Antidepressants are addictive and increase the risk of relapse
Gøtzsche, P. C. (2016) · BMJ · doi:10.1136/bmj.i574 · Cited by 5
Cited by
Prepandemic psychotropic drug status in Portugal: a nationwide pharmacoepidemiological profile
Madeira, L., Queiroz, G., & Henriques, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33765-0 · Cited by 143
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
Symptoms of anxiety and depression and risk of atrial fibrillation—The HUNT study
Feng, T., Malmo, V., Laugsand, L. E., Strand, L. B., Gustad, L. T., Ellekjær, H., Loennechen, J. P., Mukamal, K. J., & Janszky, I. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.11.107 · Cited by 65
Exploration of GP perspectives on deprescribing antidepressants: a qualitative study
Kelly, D., Graffi, J., Noonan, M., Green, P., Mcfarland, J. W., Hayes, P., & Glynn, L. G. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046054 · Cited by 36
Metadata
- Authors
- Verhaak, P. F. M., de Beurs, D., & Spreeuwenberg, P.
- Affiliations
- University Medical Center Groningen (NL)
- Netherlands Institute of Health Services Research (NIVEL), Utrecht, The Netherlands
- Netherlands Institute for Health Services Research (NL)
- Corresponding author
- Verhaak, Peter F M
- ORCID
- Verhaak, Peter F M
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2019-02
- Volume
- 9
- Issue
- 2
- Pages
- e024051
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC6377556
- OpenAlex
- W2913698857
- Cited by
- 45
- References
- 40
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 3 · 2020: 7 · 2019: 2
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
- Funders
- Nederlands Instituut voor Onderzoek van de Gezondheidszorg
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- antidepressant prescribing, long-term antidepressant use, selective serotonin reuptake inhibitors, tricyclic antidepressants, depression, anxiety, general practice, prescribing patterns, sex differences, age differences, clinical practice variation
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Antidepressive Agents, Anxiety, Depression, Female, Humans, Longitudinal Studies, Male, Middle Aged, Netherlands, Practice Patterns, Physicians', Drug Prescriptions, Sex Factors, Time Factors, Young Adult, General Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
